Skip to content
TrialScanner

NCT01937468

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Phase 1Active, not recruitingIOVACollaborator

Registry record

Lead sponsor
Dana-Farber Cancer Institute
Conditions
Chronic Graft Versus Host Disease; Chronic GVHD; Complications of Organ Transplant Stem Cells
Primary completion
Aug 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01937468 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

1 change recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.